DK0804736T3 - Ultra-sensitive method for the determination of cardiac troponin I - Google Patents

Ultra-sensitive method for the determination of cardiac troponin I

Info

Publication number
DK0804736T3
DK0804736T3 DK96901825T DK96901825T DK0804736T3 DK 0804736 T3 DK0804736 T3 DK 0804736T3 DK 96901825 T DK96901825 T DK 96901825T DK 96901825 T DK96901825 T DK 96901825T DK 0804736 T3 DK0804736 T3 DK 0804736T3
Authority
DK
Denmark
Prior art keywords
ultra
determination
cardiac troponin
sensitive method
sensitive
Prior art date
Application number
DK96901825T
Other languages
Danish (da)
Inventor
Charles Calzolari
Odile Flecheux
Bernard Pau
Original Assignee
Pasteur Sanofi Diagnostics
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Sanofi Diagnostics filed Critical Pasteur Sanofi Diagnostics
Application granted granted Critical
Publication of DK0804736T3 publication Critical patent/DK0804736T3/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/577—Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies; monoclonal antibodies per se are classified with their corresponding antigens
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/324—Coronary artery diseases, e.g. angina pectoris, myocardial infarction

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • External Artificial Organs (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Steroid Compounds (AREA)

Abstract

The present invention relates to a ultrasensitive process for assaying cardiac troponine I by means of chemiluminescence.
DK96901825T 1995-01-19 1996-01-19 Ultra-sensitive method for the determination of cardiac troponin I DK0804736T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9500597A FR2729759A1 (en) 1995-01-19 1995-01-19 ULTRASENSITIVE DOSING METHOD FOR THE CARDIAC TROPONIN I
PCT/FR1996/000095 WO1996022535A1 (en) 1995-01-19 1996-01-19 Ultrasensitive process for assaying cardiac troponine i

Publications (1)

Publication Number Publication Date
DK0804736T3 true DK0804736T3 (en) 1999-10-18

Family

ID=9475293

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96901825T DK0804736T3 (en) 1995-01-19 1996-01-19 Ultra-sensitive method for the determination of cardiac troponin I

Country Status (13)

Country Link
EP (1) EP0804736B1 (en)
JP (1) JP3558643B2 (en)
KR (1) KR100237239B1 (en)
CN (1) CN1105306C (en)
AT (1) ATE178410T1 (en)
AU (1) AU703944B2 (en)
BR (1) BR9607164A (en)
DE (1) DE69601922T2 (en)
DK (1) DK0804736T3 (en)
ES (1) ES2131929T3 (en)
FR (1) FR2729759A1 (en)
GR (1) GR3030113T3 (en)
WO (1) WO1996022535A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0871887B1 (en) * 1995-06-07 2007-03-28 BioVeris Corporation Electrochemiluminescent enzyme immunoassay
US7407767B2 (en) 2003-04-16 2008-08-05 Ono Pharmaceutical Co., Ltd. Method of screening remedy for heart disease and medicinal composition for treating heart disease
CN101105497B (en) * 2006-07-13 2011-10-19 上海凯创生物技术有限公司 Cardiac muscle troponin I detection reagent kit and its preparation method
US20110136141A1 (en) * 2009-12-03 2011-06-09 Abbott Laboratories Peptide reagents and method for inhibiting autoantibody antigen binding
CN102183657B (en) * 2011-02-24 2014-02-05 南京基蛋生物科技有限公司 Method for greatly improving chemiluminescence magnetic enzyme immunization sensitivity by depending on polystyrene nanoparticles
US8603760B2 (en) 2011-12-20 2013-12-10 Panasonic Corporation Recombinant protein capable of binding specifically and quickly to troponin I derived from human myocardium
JPWO2013094080A1 (en) * 2011-12-20 2015-04-27 パナソニックヘルスケア株式会社 Recombinant protein capable of binding specifically and rapidly to human cardiac muscle-derived troponin I
JPWO2013099043A1 (en) * 2011-12-26 2015-04-30 パナソニックヘルスケア株式会社 Recombinant protein capable of binding specifically and rapidly to human cardiac muscle-derived troponin I
CN102735848A (en) * 2012-07-05 2012-10-17 北京源德生物医学工程有限公司 Enzymatic chemiluminescence immunodetection method and reagent kit for human troponin I
WO2016048388A1 (en) 2014-09-26 2016-03-31 Somalogic, Inc. Cardiovascular risk event prediction and uses thereof
CN105132383A (en) * 2015-07-25 2015-12-09 大庆麦伯康生物技术有限公司 Hybridomas capable of producing anti-cTnI (cardiac troponini I) monoclonal antibodies
JP6651794B2 (en) * 2015-11-05 2020-02-19 富士レビオ株式会社 Cardiac troponin I measuring reagent and method
WO2017171293A1 (en) * 2016-03-31 2017-10-05 (주) 인텍플러스 Method for highly sensitive biomarker quantification using photo-oxidation amplification
CN110031635A (en) * 2019-05-16 2019-07-19 杭州普鲁米生物科技有限公司 Flash type homogeneous chemistry luminescence technology detects cardiac muscle troponin I/T method
CN112014573B (en) * 2020-08-25 2023-08-08 武汉生之源生物科技股份有限公司 Preparation method of high-sensitivity assay kit for troponin I in human whole blood sample and kit

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3463395D1 (en) * 1983-02-11 1987-06-04 Nat Res Dev Enhanced luminescent or luminometric assay
US4931223A (en) * 1986-07-24 1990-06-05 Tropix, Inc. Methods of using chemiluminescent 1,2-dioxetanes
US5336596A (en) * 1991-12-23 1994-08-09 Tropix, Inc. Membrane for chemiluminescent blotting applications
DE69420556T2 (en) * 1993-05-17 2000-03-23 Fortron Bioscience, Inc. ASSAY FOR TROPONIN I FROM THE HEART MUSCLE

Also Published As

Publication number Publication date
AU4625196A (en) 1996-08-07
CN1176002A (en) 1998-03-11
WO1996022535A1 (en) 1996-07-25
DE69601922T2 (en) 1999-10-07
DE69601922D1 (en) 1999-05-06
GR3030113T3 (en) 1999-07-30
CN1105306C (en) 2003-04-09
MX9705411A (en) 1997-11-29
BR9607164A (en) 1997-11-11
JPH10512672A (en) 1998-12-02
EP0804736B1 (en) 1999-03-31
ES2131929T3 (en) 1999-08-01
FR2729759A1 (en) 1996-07-26
KR100237239B1 (en) 2000-01-15
AU703944B2 (en) 1999-04-01
EP0804736A1 (en) 1997-11-05
JP3558643B2 (en) 2004-08-25
ATE178410T1 (en) 1999-04-15
KR19980701608A (en) 1998-06-25

Similar Documents

Publication Publication Date Title
DK0804736T3 (en) Ultra-sensitive method for the determination of cardiac troponin I
DK0708922T3 (en) Identification of ligands by selective amplification of cells transfected with receptors
ES2145915T3 (en) STEREOCHEMICAL DERIVATIVES OF WORTMANNINA.
ATE153332T1 (en) METHOD FOR PRODUCING OXETANONES
DK162267C (en) METHOD OF PRESSING FOR METAL ARTICLES
LU79812A1 (en) METHOD FOR THE PRODUCTION OF ANTIBODY
MX9205035A (en) NEMATOCID METHOD
DK0539435T3 (en) Method for reducing interferences by a fluorescence assay
EA199800792A1 (en) METHODS OF OBTAINING INTERMEDIATE CONNECTIONS FOR PESTICIDES
DE69900465D1 (en) A SCREENING PROCEDURE BASED ON FLUORESCENT POLARISATION
EA199800123A1 (en) METHOD FOR PRODUCING N-SUBSTITUTED 3-HYDROXYPYRAZOLES
DK0862683T3 (en) Method for determining the quality of a borehole measurement
DK1025083T3 (en) Method for stereoselective synthesis of prostacyclin derivatives
DK162266C (en) METHOD OF PRESSING FOR METAL ARTICLES
ATE221657T1 (en) DISTURBANCE BY RHEUMA FACTORS
DK26587D0 (en) MONOCLONAL ANTIBODY, METHOD OF GLUCOSYLATED PROTEIN USING THE MONOCLONAL ANTIBODY KIT, INCLUDING THIS
EA199900948A1 (en) Method of producing 2-aryl-3-aryl-5-halogenpyridines used as COX-2 inhibitors
EA200100129A1 (en) METHOD OF OBTAINING HYDROXYMETHYLBYTHEBUTANE ACID
EA199900741A1 (en) METHOD OF OBTAINING EPROSARTANA
KR850002010A (en) Method for producing heterocyclic compound
EA199900740A1 (en) METHOD OF OBTAINING EPROSARTAN (OPTIONS)
NO812394L (en) PROCEDURE FOR AA DETERMINING THE PH VALUE OF ION-WATER
EA200100131A1 (en) METHOD OF OBTAINING VITAMIN A
EA200000069A1 (en) METHOD FOR OBTAINING 4-SUBSTITUTED-1H-INDOL-3-GLYOXAMIDES
EA200200162A1 (en) LIPEPEPIPEPTIDES DEACYLATION METHOD